AUPR589701A0 - Novel peptide and use thereof - Google Patents
Novel peptide and use thereofInfo
- Publication number
- AUPR589701A0 AUPR589701A0 AUPR5897A AUPR589701A AUPR589701A0 AU PR589701 A0 AUPR589701 A0 AU PR589701A0 AU PR5897 A AUPR5897 A AU PR5897A AU PR589701 A AUPR589701 A AU PR589701A AU PR589701 A0 AUPR589701 A0 AU PR589701A0
- Authority
- AU
- Australia
- Prior art keywords
- novel peptide
- peptide
- novel
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
- C07K14/4713—Autoimmune diseases, e.g. Insulin-dependent diabetes mellitus, multiple sclerosis, rheumathoid arthritis, systemic lupus erythematosus; Autoantigens
Priority Applications (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AUPR5897A AUPR589701A0 (en) | 2001-06-22 | 2001-06-22 | Novel peptide and use thereof |
AU2001288087A AU2001288087A1 (en) | 2001-06-22 | 2001-09-21 | Polypeptides comprising t cell epitopes from alpha-fodrin and the uses thereof in treatment of sjogren's syndrome |
PCT/JP2001/008221 WO2003000718A2 (en) | 2001-06-22 | 2001-09-21 | Polypeptides comprising t cell epitopes from alpha-fodrin and the uses thereof in treatment of sjögren's syndrome |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AUPR5897A AUPR589701A0 (en) | 2001-06-22 | 2001-06-22 | Novel peptide and use thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
AUPR589701A0 true AUPR589701A0 (en) | 2001-07-19 |
Family
ID=3829866
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AUPR5897A Abandoned AUPR589701A0 (en) | 2001-06-22 | 2001-06-22 | Novel peptide and use thereof |
AU2001288087A Abandoned AU2001288087A1 (en) | 2001-06-22 | 2001-09-21 | Polypeptides comprising t cell epitopes from alpha-fodrin and the uses thereof in treatment of sjogren's syndrome |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU2001288087A Abandoned AU2001288087A1 (en) | 2001-06-22 | 2001-09-21 | Polypeptides comprising t cell epitopes from alpha-fodrin and the uses thereof in treatment of sjogren's syndrome |
Country Status (2)
Country | Link |
---|---|
AU (2) | AUPR589701A0 (en) |
WO (1) | WO2003000718A2 (en) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN100572391C (en) * | 2006-08-30 | 2009-12-23 | 中国科学院广州生物医药与健康研究院 | Beta-fodrin antigen epitope polypeptide and screening method thereof and application |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH10251157A (en) * | 1996-04-23 | 1998-09-22 | Yoshio Hayashi | Medicine containing alpha-fodrin or alpha-fodrin fragment protein |
CA2188816C (en) * | 1996-04-23 | 2009-09-22 | Takeda Chemical Industries, Ltd. | Composition containing .alpha.-fodrin or .alpha.- fodrin fragment protein |
-
2001
- 2001-06-22 AU AUPR5897A patent/AUPR589701A0/en not_active Abandoned
- 2001-09-21 WO PCT/JP2001/008221 patent/WO2003000718A2/en active Application Filing
- 2001-09-21 AU AU2001288087A patent/AU2001288087A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
WO2003000718A3 (en) | 2003-08-21 |
AU2001288087A1 (en) | 2003-01-08 |
WO2003000718A2 (en) | 2003-01-03 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2002315389A1 (en) | Novel pyrazolo-and pyrrolo-pyrimidines and uses thereof | |
AU2002315388A1 (en) | Novel phenylamino-pyrimidines and uses thereof | |
EP1414848A4 (en) | Replikin peptides and uses thereof | |
EP1419175A4 (en) | Replikin peptides and uses thereof | |
EP1462455A4 (en) | Novel peptides and medicinal uses thereof | |
AU2002307031A1 (en) | Thrombospondin-2 and uses thereof | |
EP1408985A4 (en) | Novel pyridopyrimidones and uses thereof | |
AU2002312373A1 (en) | Structural and cytoskeleton-associated proteins | |
AU2002230129A1 (en) | Novel physiologically active peptide and use thereof | |
AU2002251543A1 (en) | Novel atisane compound and use thereof | |
AUPR548601A0 (en) | Pyrazolopyrazinecompound and pharmaceutical use thereof | |
AUPR589701A0 (en) | Novel peptide and use thereof | |
AU2003292774A1 (en) | Novel proteins and use thereof | |
AU2003280992A1 (en) | Novel proteins and use thereof | |
AU2002357609A1 (en) | Novel proteins and dnas thereof | |
AU2002343516A1 (en) | Structural and cytoskeleton-associated proteins | |
AU2002320621A1 (en) | Structural and cytoskeleton-associated proteins | |
AU2002311203A1 (en) | Novel polypeptide and use thereof | |
SG10201403662QA (en) | Replikin peptides and uses thereof | |
AU2002230137A1 (en) | Novel protein and use thereof | |
AU2003238562A1 (en) | Novel peptide and use thereof | |
AU2002354188B2 (en) | Novel peptides and medicinal uses thereof | |
AU2002341133A1 (en) | Modified peptides and their uses | |
WO2002061044A9 (en) | Synthetic peptide and uses for same | |
AU2002228426A1 (en) | Neurotonin and use thereof |